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Abstract
Many pharmacological agents were investigated for the prevention of renal ischemic reperfusion (I/R) injury as well as the phosphodiesterase 
(PDE) inhibitors. Th e aim of the study was to examine the possible renoprotective eff ect of a member in this family, tadalafi l (Td) on I/R injury. 
Th irty-six Spraque Dawley rats were allocated to six groups as; control, sham, ischemia (I), ischemia/reperfusion (I/R), Td pretreatment isch-
emia (Td/I) and Td pretreatment ischemia/reperfusion (Td/IR) groups. Right nephrectomy was performed in all groups. Td was dissolved in 
saline solution and given as a single dose (mg/kg) through an orogastrictube  min before the operation in the Td pretreatment groups. In 
ischemia group the left renal pedicle was occluded for  minutes and after than underwent left nephrectomy. In I/R group left renal pedicle 
was occluded for  minutes, reperfused for hour and after then underwent nephrectomy. Th e left kidneys were evaluated after standard 
laboratory procedures with regard to tubular morphology, and leukocyte infi ltration. Th e data were analyzed by using Kruskal–Wallis test to 
determine diff erences among the groups. A p value of < . was considered signifi cant. 
Renal tubular damage was signifi cant increased in the ischemia and I/R group (Groups III and IV) when compared to those in the sham group 
(Group II), (p = ., ., respectively). Tubular damage, in the Td pretreatment ischemia (Td/I) (Group V) and Td pretreatment ischemia/
reperfusion (Td/IR) (Group VI) were less than that in the ischemia group (Group III) (p= ., p= ., respectively). 
Td administration prior to the renal I/R injury attenuated these morphological disarrangements, which were observed in renal I/R. Tubular 
necrosis, which may be considered as an important issue of the developing renal injury, was also completely prevented with Td administration.
 ©  Association of Basic Medical Sciences of FBIH. All rights reserved
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INTRODUCTION
As a consequence of hemorrhage, shock, cardiac arrest, renal 
artery surgery, or renal transplantation, I/R injury remains a 
major clinical problem []. Preventing the renal tissue from 
IR injury is the main aim of the intense researches about 
these ischemic phenomenons []. PDE inhibitors are the 
compounds those inhibit or antagonize the biosynthesis or 
actions of PDEs. PDE  inhibitors are currently widely used 
for the treatment of pulmonary arterial hypertension and 
erectile dysfunction in men [-]. Th ese vasodilator and ino-
tropic agents have protective eff ects on vascular structures 
and myocardial muscles [-]. Th e eff ects of many members 
in this family have been studied especially on I/R injury. In 
the literature sildenafi l citrate and vardenafi l HCl are most 
commonly investigated PDE inhibitors for this subject 
[-]. Aim of our study is to determine the eff ects of Td 
on renal I/R injury by using histopathological parameters. 
MATERIALS AND METHODS 
All experiments in this study were performed in accordance 
with the guidelines for animal research from the National In-
stitutes of Health and were approved by our university Ani-
mal Ethics Committee.
Experimental groups 
Male Spraque Dawley rats weighing – g were ran-
domly divided into six groups each with six animals. Td 
was dissolved in saline solution and given as a single dose 
(mg/kg) through an orogastrictube  min before the op-
eration in the Td pretreatment groups. Th e rats were anes-
thetized with intraperitoneal injection of ketamine. An 
upper abdominal midline incision was made and bilateral 
renal blood vessels were isolated using minimal dissection. 
In Group I (control), only right nephrectomy was performed. 
Animals in Group II (sham) were subjected to right nephrec-
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tomy and left nephrectomy was performed after waiting for 
 minutes without any ischemia. In Group III (ischemia 
group), rats were subjected to right nephrectomy and the left 
renal pedicle was occluded for  minutes with microvascular 
clamps and after than underwent left nephrectomy. In Group 
IV (I/R group), rats were subjected to right nephrectomy, oc-
clusion of left renal pedicle for  minutes and reperfusion 
for hour and after then underwent nephrectomy. Animals 
in Group V (Td + Ischemia) were subjected to right nephrec-
tomy and the left renal pedicle was occluded for  minutes 
with microvascular clamps and after than underwent left 
nephrectomy. In GroupVI (T+I/R) rats subjected to right ne-
phrectomy, occlusion of left renal pedicle for  minutes and 
reperfusion for hour and after then underwent nephrectomy. 
Histopathological evaluation
Left kidneys were fixed with formalin, embeded in paraf-
fi n and stained with hematoxylin eosin. All were evaluated 
by the same pathologist with respect to glomerular, tubular, 
and interstitial morphology. Sclerosis of glomeruli was noted. 
About one hundred tubules of the kidney were evaluated ran-
domly and were scored for each section. Th e mean score was 
calculated for each of the six groups. Tubular morphology 
was determined in four groups as:  (normal morphology),  
(mild brush border abnormality such 
as fl attening, or irregularity in shape 
and size of the cells),  (moderate 
brush border abnormality, involving 
more than  of the tubular profi les), 
 (loss of microvilli in the epithelium 
of whole tubules and tubular necrosis).
In addition, leukocyte infiltration 
was evaluated in four areas of the 
sections as -point scoring system: 
 = normal,  = infiltration less than 
,  = infi ltration between  and 
,  = infiltration more than . 
Statistical analysis
Statistical analysis was done by using the Statistical Pack-
age for Social Sciences, version . for Windows, (SPSS, 
Chicago, IL). Histological damage among the groups 
was compared using the Kruskal-Wallis test. The val-
ue of p < . was considered statistically significant. 
RESULTS 
Microscopic evaluation of the control and sham groups 
(Group I -II) revealed a regular morphology of renal paren-
chyma (Figure ). The kidneys in ischemia group (Group 
III) showed sclerosis of glomeruli. Bowman’s space was 
enlarged. There was loss of micro- villi in the epithelium 
of proximal tubules (Figure -A, B). Tubular necrosis was 
found in both cortical and medullar regions. Enlargement of 
the interstitium was seen as a result of edema (Figure -C). 
Tubular degeneration was evident in I/R group (Group IV).
Necrosis in the tubular epithelium of the cortex and 
hyaline degeneration in some areas were observed. The 
loss of microvilli in epithelial cells of proximal tubule 
was evident (Figure -A). Interstitial edema and leuko-
cyte infiltration were found in the medulla (Figure - B). 
In Td + Ischemia group (Group V), capillaries in glom-
eruli showed normal morphology (Figures -A). In some 
FIGURE 1.  Regular morphology of 
renal parenchyma (Hematoxylin–
eosin x 100)
FIGURE 2.  (A) Sclerosis of glomeruli and enlargement of Bowman space (Hematoxylin–
eosin x 200). (B) Loss of microvilli and fl attened cells in the epithelium of proximal tubules 
(Hematoxylin–eosin x 400). (C) Interstitial edema (Hematoxylin–eosin x 200).
A B
FIGURE 3.  (A) Loss of microvilli in the epithelium of proximal tubules (Hematoxylin–eosin 
x 400). (B) Leukocyte infi ltration between tubules and around blood vessel (Hematoxylin–
eosin x 400)
A B
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areas, loss of microvilli was obvious in sections (Figure 
-B). Interstitial edema was prominent, particularly near 
blood vessels (Figure -C). In Td + I/R group (Group-
VI) the kidney preserved the normal morphology, and 
showed normal morphology of glomeruli and tubular cells. 
Most of epithelial  cells l ining the proximal tu-
bules were preserving microvilli structure (Figures 
-A). Stasis, congestion and hemorrhage in some 
sections were found in the medulla (Figure -B).
Renal tubular damage was signifi cantly increased in the isch-
emia and I/R group (Groups III and IV) when compared 
to those in the sham group (Group II), (p = ., ., re-
spectively). Tubular necrosis and loss of microvilli was less 
in Td + ischemia group (Group V) and Td pretreated I/R 
group (GroupVI) according to ischemia group (p = ., p = 
. respectively). With regard to histopathological scoring, 
tubular damage in the Td pretreated I/R group (GroupVI) 
was less than in the I/R group (Group IV) (Median score 
 and  respectively). However, the difference between 
the Td pretreated I/R group (GroupVI) and I/R (Group IV) 
groups was not signifi cant (p = ,). But tubular necrosis 
was signifi cant increased in Td pretreated ischemia group 
(Group V) and Td pretreated I/R group (GroupVI) when 
compared to sham group (p = ., p = ., respectively).
According to histopathological scoring the leukocyte in-
fi ltration score in the sham group (Group I) was . (Table 
). It was increased in the ischemia (Group II) and I/R 
group (Group III) when compared to the sham group 
(Group I) (median score . and ., respectively). The 
leukocyte infiltration score was decreased in the Td pre-
treated ischemia group (Group V) and Td pretreated I/R 
group (Group VI) when compared to I/R group (Group 
IV). (Median score . and .) (Table ). However, the dif-
ference between the Td pretreated ischemia group (Group 
V), Td pretreated I/R group (Group VI) and I/R (Group 
IV) groups was not statistically significant (p = .).
DISCUSSION
PDE is a family of enzymes that 
regulate the cellular levels of sec-
ond messengers, cyclic adenosine 
monophosphate (cAMP) and cy-
clic guanosine monophosphate 
(cGMP) []. Eleven types of differ-
ent PDE families were defi ned in the 
literature []. Every type with its 
own properties modulates distinct 
regulatory pathways in the cell; thus, 
targeting specific PDE offers a fine 
FIGURE 4.  (A) Normal morphology of capillaries in glomeruli (Hematoxylin–eosin x 200). (B) Obvious loss of microvilli in some areas 
(Hematoxylin–eosin x 400). (C) Prominent interstitial edema near blood vessels (Hematoxylin–eosin x 200).
A B C
Groups n




I Control 6 13.6 0.40
II Sham 6 14.1 0.25
III Ischemia 6 59 0.8
IV I/R 6 44 1.5
V Td/I 6 34 0.5
VI Td/IR 6 28 0.5
TABLE 1.  Median tubular morphology and neutrophil infi ltration 
scores.
A B
FIGURE 5.  (A) Glomeruli and tubular cells showed normal appearance (Hematoxylin–eo-
sin x 200). (B) Stasis, congestion and hemorrhage in some sections of medulla (Hematoxy-
lin–eosin x 100).
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way to treat a disease [, ]. PDE  is found in high con-
centration in vascular smooth muscle cells of the corpora 
cavernosa of the penis, in smooth muscle cells of the periph-
eral arterial and venous vessels as well as coronary and pul-
monary circulation, and in platelets []. It is specific for 
the hydrolysis of cGMP []. cGMP plays an important role 
in regulation of intracellular calcium levels, modulation of 
platelet function and induces vasodilatation in I/R injury [].
During ischemia on a kidney leads to vascular endothe-
lial injury [, ]. Increased vascular resistance, produced 
by the loss of the ability of renal vascular endothelium to 
release nitric oxide (NO), or an imbalance between NO 
and endothelin- production []. NO has been shown to 
act via a variety of second-messenger cascades, although 
most of its effects are mediated by cGMP [, ]. At 
this point, PDE inhibitors may enhance the production 
of cGMP by removing away PDE. They increase the re-
lease of NO and improve endothelial dysfunction [, ]. 
In the literature few studies examined the eff ects of PDE in-
hibitors on renal I/R injury. Chintala et al. [] found that a 
selective cGMP PDE inhibitor, Zaprinast, had anti-platelet 
effects following I/R in rats. According to Guan et al, the 
same drug enhanced renal blood fl ow by stimulating intra-
cellular cGMP in ischemic acute renal failure in rats []. 
Lledo-Garcia et al. [] reported that sildenafi l has improved 
the outcome of warm-ischemic kidneys on the immediate 
posttransplant period. Oruc et al. [] revealed that pre-
ischemic treatment with sildenafi l citrate can signifi cantly 
attenuate I/R-induced renal injury by decreasing leukocyte 
infi ltration. Although the protective eff ects of Sildenafi l and 
vardenafil in renal I/R injury have been examined and ac-
cepted in several studies, there is only one study in the lit-
erature about the eff ect of Td in renal I/R injury []. Td is 
a class of mild vasoactive drugs developed for the treatment 
of erectile dysfunction ED []. It has a different chemical 
structure from sildenafi l and vardenafi l with a mean time to 
maximum plasma concentration of  h which is two times 
longer than other molecules [, , , ]. Th e half-lives of 
sildenafi l and vardenafi l are  h and that of tadalafi l is . 
h []. Th ese advanced features make this molecule a good 
option in the treatment of regulation of decreased vascular 
resistance and ischemia. Th ere are several studies with Td 
investigating eff ects on diff erent organs. According to Sesti 
et al. [] Td was cardioprotective in the setting of an experi-
mental myocardial infarction. Sawamura et al. [] suggested 
that Td relaxes pulmonary arteries in lungs and treatment 
occurs in the late phase of pulmonary arterial hypertension. 
According to the only study in the literature, the effect of 
Td can be attributed to its protective eff ects on renal tubu-
lar cells and inhibition of leukocyte infi ltration in renal tis-
sue []. Renal tubular epithelium damage plays an active 
role in initiating the infl ammatory response [, ]. During 
ischemic periods, renal leukocyte infiltration is activated 
and increased [, ]. Activated neutrophils can release 
cytokines, reactive oxygen species, proteases, myeloperoxi-
dase and other enzymes to trigger further damage [, ]. 
In the present study, tubular morphology in Td pretreated 
ischemia group and Td pretreated I/R group were signifi-
cantly better than that in ischemia group. Although there 
was no statistical significance, leukocyte infiltration was 
decreased in Td pretreated ischemia and Td pretreated I/R 
group when compared to the I/R group. Moreover, further 
studies will be necessary to determine the role of cGMP 
levels and renal blood fl ow in ischemia–reperfusion injury.
CONCLUSION
Th is study is the second in the literature to demonstrate the 
protective eff ects of Td in experimental renal I/R injury model 
in the rat. Th e results of our study have demonstrated that giv-
en as a single dose Td administration prior to the renal I/R in-
jury attenuated these morphological disarrangements, which 
were observed in renal I/R. Tubular necrosis, which may be 
considered as an important issue of the developing renal in-
jury, was also completely prevented with Td administration. 
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